United Therapeutics Corp

Change company Symbol lookup

Select an option...

UTHR United Therapeutics Corp

HGKGY Power Assets Holdings Ltd

ICPT Intercept Pharmaceuticals Inc

KEY KeyCorp

TTWO Take-Two Interactive Software Inc

TOPS Top Ships Inc

BOLT Bolt Biotherapeutics Inc

ACET Adicet Bio Inc

VCNX Vaccinex Inc

DYNT Dynatronics Corp

Go

3D Systems' (DDD) collaboration with Klarity is likely to help it in expanding the distribution of its FDA-approved VSP Bolus solution.(Zacks)

--UThymoKidney(TM) demonstrates normal function during a 61-day study --Human xenotransplant clinical studies could begin in 2025 United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the achievement of two...(BusinessWire)

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its 2023 Corporate Responsibility and Public Benefit Report covering its 2022 progress toward its public benefit goals and objectives...(BusinessWire)

Sector ETF report for PBE(Zacks)

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company's business during a fireside chat session at...(BusinessWire)

Smart Beta ETF report for PBE(Zacks)

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2023. Total revenues in the second quarter of 2023 grew 28% year-over-year to $596.5 million, compared...(BusinessWire)

United Therapeutics (UTHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.(Zacks)

United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its second quarter 2023 financial results before the market opens on Wednesday, August 2, 2023. United Therapeutics will host a public webcast Wednesday, August 2...(BusinessWire)

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States Court of Appeals for the Federal Circuit affirmed the district court decision in the patent litigation United Therapeutics brought...(BusinessWire)

United Therapeutics' (UTHR) first-quarter 2023 earnings beat estimates while sales miss the same. Tyvaso sales continue to drive the company's top line.(Zacks)